Stack analysis
CoQ10 + PQQ ‘mitochondrial’ stack
Mitochondrial energy and longevity marketing bundles.
Confidence
56/100
Registry ingredients
Structured entries from our supplement intelligence registry (not personalized recommendations).
- Coenzyme Q10 (ubiquinone / ubiquinol)compound
Evidence tier: medium·Typical label range: Often 100-300 mg/day with fat-containing meal.
- PQQ (pyrroloquinoline quinone)vitamin
Evidence tier: low·Typical label range: Common supplement doses ~10-20 mg/day in trials/small studies.
What this stack claims
More energy, better cognition, cardioprotection - often extrapolated from small or mechanistic work.
Biological logic
CoQ10 is a redox-active electron carrier; PQQ is marketed around mitochondrial biogenesis themes; mechanistic stories exist, human translation is thinner for PQQ especially.
Evidence level
Registry tier for this stack: LOW
CoQ10 has clearer niches (e.g., statin-associated muscle symptoms in some trials, some HF contexts under cardiology care). PQQ human outcome replication is limited. The pair is retail synergy more than proven synergy.
Risks
Cost; warfarin interaction debates for CoQ10; unknown long-term marginal benefit; distraction from treatable causes of fatigue (sleep apnea, anemia, thyroid, depression).
Final verdict
**Overhyped as a general energy stack**; CoQ10 may deserve a targeted role; PQQ is speculative for most buyers.
FAQ
- Ubiquinol vs ubiquinone?
- Bioavailability differs by product and person; debate continues - brand quality matters more than hype words.
- Will blood tests show a deficiency?
- CoQ10 testing is not routine; clinical indication drives use more than consumer lab panels.
- Safe with heart meds?
- Coordinate with cardiology/pharmacy - polypharmacy is common in the exact population attracted to this stack.